Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
(Reuters) – Merck on Wednesday agreed to acquire privately held biotech EyeBio for as much as $3 billion, the latest…
(Reuters) – Merck on Wednesday agreed to acquire privately held biotech EyeBio for as much as $3 billion, the latest…
WASHINGTON (Reuters) – Donald Trump is considering tapping billionaire Elon Musk as a policy adviser if the Republican presidential candidate…
(Reuters) – U.S. economic activity continued to expand from early April through mid-May but firms grew more pessimistic about the…
By Deena Beasley (Reuters) – As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies,…
By Zaheer Kachwala (Reuters) – Nvidia’s shares rallied around 6% to hit a record high on Tuesday, leaving the AI…
BEIJING (Reuters) – Chinese Premier Li Qiang told Samsung Chairman Jay Y. Lee on Sunday that China welcomed further investment…
(Please note language in paragraph 18 that readers may find offensive) By Tim Reid WASHINGTON (Reuters) – Presidential candidate Donald…
(Reuters) – Anglo American was pressed by key shareholders including BlackRock to extend talks with BHP Group over its proposed…
KYIV (Reuters) – Ukrainian President Volodymyr Zelenskiy appealed to U.S. President Joe Biden and Chinese leader Xi Jinping on Sunday…
HSINCHU, Taiwan (Reuters) -Taiwanese contract chipmaker TSMC, a major supplier to Apple and Nvidia, on Thursday forecast an annual revenue…